HNF1A-AS1 promotes oral squamous cell carcinoma progression via regulating miR-138/CDK6 pathway

被引：0

作者：

Mei, Bingxin ^{[1
]}

Zeng, Zhimei ^{[1
]}

Xia, Qinmin ^{[1
]}

Liu, Ming ^{[1
]}

Lei, Li ^{[1
]}

机构：

[1] Gannan Med Univ, Dept Stomatol, Affiliated Hosp 1, 128 Jinling Rd, Ganzhou 341000, Jiangxi, Peoples R China

来源：

ODONTOLOGY | 2025年

关键词：

HNF1A-AS1; miR-138; CDK6; Progression; OSCC; UP-REGULATION; RESISTANCE;

D O I：

10.1007/s10266-025-01057-w

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

The action and the latent mechanism of HNF1A-AS1 in oral squamous cell carcinoma (OSCC) development were probed. Levels of HNF1A-AS1, microRNA-138 (miR-138) and Cyclin-dependent kinase 6 (CDK6) were examined. In vitro assays were conducted using SCC-4 and SCC15 cells derived from a human SCC of the tongue of a 55-year-old male. In vivo assay was performed by establishing OSCC mouse models. An elevated HNF1A-AS1 was detected in OSCC, and down-expressed HNF1A-AS1 inhibited migration and invasion, and promoted apoptosis in OSCC cells in vitro. HNF1A-AS1 targeted miR-138 to positively regulate the expression of CDK6, a target of miR-138. Knockdown of miR-138 attenuated the action of HNF1A-AS1 silencing on OSCC cell malignant phenotypes. Besides that, overexpression of CDK6 weakened miR-138-mediated anti-cancer functions. Moreover, HNF1A-AS1 knockdown restrained OSCC growth in nude mice. HNF1A-AS1 promoted OSCC tumorigenesis via miR-138/CDK6 pathway, indicating the potential molecular contribution of HNF1A-AS1 on OSCC pathogenesis.

引用

页数：11

共 50 条

[41] LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway
Bao, Jie
Chen, Xiaoqi
Hou, Yuge
Kang, Gailing
Li, Qiaoli
Xu, Yun
BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 824 - 833
[42] Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway
Cui, Xiangyan
Yu, Tingting
Shang, Jing
Xiao, Dong
Wang, Xin
ONCOTARGETS AND THERAPY, 2019, 12 : 8853 - 8862
[43] MiR-384 represses tumorigenesis by regulating CDK6 and predicts prognosis of clear cell renal cell carcinoma
Guo, Lihua
Wang, Dayu
Zhang, Zhiping
JOURNAL OF BUON, 2018, 23 (03): : 787 - 794
[44] Downregulation of miR-138 Sustains NF-κB Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma
Gong, Hui
Song, Libing
Lin, Chuyong
Liu, Aibin
Lin, Xi
Wu, Jueheng
Li, Mengfeng
Li, Jun
CLINICAL CANCER RESEARCH, 2013, 19 (05) : 1083 - 1093
[45] TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway
Gu, Yixue
Fan, Shasha
Liu, Binjie
Zheng, Guopei
Yu, Yanhui
Ouyang, Yongmei
He, Zhimin
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 357 (1-2) : 107 - 113
[46] NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway
Ma, Ping
Yu, Huajiao
Zhu, Mingda
Liu, Li
Cheng, Luyao
Han, Zhengxue
Jin, Wulong
CELL CYCLE, 2024, 23 (05) : 588 - 601
[47] miR-1 targets Cdk6 and controls cell cycle progression and apoptosis in colitis-associated dysplasia
Fragoso, Mariana F.
Fernandez, Geysson J.
Vanderveer, Lisa
Cooper, Harry S.
Slifker, Michael
Clapper, Margie L.
CANCER RESEARCH, 2022, 82 (12)
[48] Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis
Luo, Zimian
Yin, Yafei
Tan, Xiaojun
Liu, Kang
Chao, Zhi
Xia, Hong
LEUKEMIA RESEARCH, 2022, 113
[49] lncRNA TUG1 promotes the development of oral squamous cell carcinoma by regulating the MAPK signaling pathway by sponging miR-593-3p
Jiang, Lei
Zhou, Bing
Fu, Dongjie
Cheng, Bo
CELL CYCLE, 2022, 21 (17) : 1856 - 1866
[50] LINC01614 Promotes Oral Squamous Cell Carcinoma by Regulating FOXC1
Che, Hongze
Zhang, Xun
Cao, Luo
Huang, Wenjun
Lu, Qing
GENES, 2024, 15 (11)

← 1 2 3 4 5 →